Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.
- DOI
- 10.1111/apm.13023
- Published
- 2020 Apr
- Container
- APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/apm.13023,
title = {Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.},
author = {Chang SL and Lee SW and Yang SF and Chien CC and Chan TC and Chen TJ and Yang CC and Li CF and Wei YC},
year = {2020},
journal = {APMIS : acta pathologica, microbiologica, et immunologica Scandinavica},
doi = {10.1111/apm.13023},
url = {https://doi.org/10.1111/apm.13023}
}RIS
TY - JOUR TI - Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma. AU - Chang SL AU - Lee SW AU - Yang SF AU - Chien CC AU - Chan TC AU - Chen TJ AU - Yang CC AU - Li CF AU - Wei YC PY - 2020 JO - APMIS : acta pathologica, microbiologica, et immunologica Scandinavica DO - 10.1111/apm.13023 UR - https://doi.org/10.1111/apm.13023 ER -
APA
SL, C., SW, L., SF, Y., CC, C., TC, C., TJ, C., CC, Y., CF, L., & YC, W. (2020). Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. https://doi.org/10.1111/apm.13023
Source records
- pubmed · retrieved 2026-09-26T21:17:53.814Z